WebSep 1, 2011 · Patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) are at increased risk for developing Hodgkin's lymphoma (HL), a risk that has not decreased despite the success of combination antiretroviral therapy (cART) in the modern era. HIV-associated HL (HIV-HL) differs from HL in non-HIV-infected patients … WebMar 8, 2024 · Mayo Clinic doctors and scientists are actively involved in research that is improving diagnosis and treatment options for people living with Hodgkin's lymphoma. Mayo Clinic is an international leader in Hodgkin's lymphoma research. The Hematologic Malignancies Program conducts research related to Hodgkin's lymphoma and other …
Dr. Nele Stadtbaeumer’s Post - LinkedIn
WebAccording to the DGHO, Hodgkin's lymphoma has become the most treatable malignant cancer in adulthood since the introduction of combination chemotherapy. However, the aggressive therapies can cause severe side effects and limit the quality of life of those affected or lead to long-term effects. WebManagement of sepsis in neutropenic cancer patients: 2024 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the … tss stoffe
web.oncoletter.ch
WebImage for DGHO 2024: JAK inhibition with ruxolitinib in patients with refractory or relapsed classical Hodgkin's lymphoma: an open-label, multicentre, phase II clinical trial … WebSep 10, 2024 · PURPOSE Combined-modality treatment (CMT) with 2× ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for patients with early-stage favorable … WebNov 27, 2014 · Long-term survivors of Hodgkin lymphoma (HL) are at an increased risk for a range of late complications, with subsequent malignant neoplasm and cardiovascular disease representing the 2 leading causes of death in these patients. Raising awareness, close follow-up, and adoption of selected early-detection and risk-reduction strategies … tss stitch crochet